MedPath

Efficacy and safety of a Chinese herbal medicine formula in the management of simple obesity: Randomised placebo-controlled clinical trial

Phase 2
Completed
Conditions
Obesity
Diet and Nutrition - Obesity
Registration Number
ACTRN12607000255482
Lead Sponsor
Prof. Charlia Xue
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
80
Inclusion Criteria

•Subjects have BMI greater than 30 kg/m2;•Not involved in other clinical trials for the treatment of obesity; •Agree to avail themselves for the period of the study; and •Provide written consent for participation.

Exclusion Criteria

Subjects with one or more of the following conditions will be excluded from study:•Loosing more than 5kg in the past 3 months;•Endocrine disorders other than type 2 diabetes mellitus; •Uncontrolled hypertension; •Autoimmune or cardiovascular diseases or carrying pace-maker; •Lactating or pregnant women; •Those using drugs affecting the central nervous system or lipid lowering drugs;•Obesity known caused by pharmacotherapy;•Therapy for weight control in the last 6 months;•Kidney or hepatic disease;•Unable to read or understand English.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath